← Browse by Condition
Medical Condition

advanced solid tumors that are mtap deficient

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06130553 Phase 1, Phase 2
Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

Enrollment
234 pts
Location
United States, Austr...
Sponsor
AstraZeneca
View Trial →